Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.

Source:http://linkedlifedata.com/resource/pubmed/id/20172040

Download in:

View as

General Info

PMID
20172040